首页> Journal of cardiovascular translational research> The SGLT2 Inhibitor Canagliflozin Reduces Atherosclerosis by Enhancing Macrophage Autophagy.

The SGLT2 Inhibitor Canagliflozin Reduces Atherosclerosis by Enhancing Macrophage Autophagy.

导出 LinkOut

翻译打印收藏纠错

第一作者： Hongping,Chen

第一单位： School of Medicine, Qingdao University, Qingdao, China.;Department of Cardiology, Yuhuangding Hospital, The Fourth School of Clinical Medicine of Qingdao University, Yantai, Shandong Province, China.

作者： Hongping,Chen ^[1] ; Da,Teng ^[1] ; Bowen,Xu ^[2] ; Chunxiao,Wang ^[3] ; Hua,Wang ^[3] ; Wenjuan,Jia ^[3] ; Lei,Gong ^[3] ; Haibin,Dong ^[3] ; Lin,Zhong ^[4] ; Jun,Yang ^[5]

作者单位： School of Medicine, Qingdao University, Qingdao, China.;Department of Cardiology, Yuhuangding Hospital, The Fourth School of Clinical Medicine of Qingdao University, Yantai, Shandong Province, China. ^[1] Binzhou Medical University, Yantai, Shandong Province, China. ^[2] Department of Cardiology, Yuhuangding Hospital, The Fourth School of Clinical Medicine of Qingdao University, Yantai, Shandong Province, China. ^[3] Department of Cardiology, Yuhuangding Hospital, The Fourth School of Clinical Medicine of Qingdao University, Yantai, Shandong Province, China. yizun1971@126.com. ^[4] Department of Cardiology, Yuhuangding Hospital, The Fourth School of Clinical Medicine of Qingdao University, Yantai, Shandong Province, China. yangjyhd@163.com. ^[5]

关键词 Atherosclerosis Autophagy Macrophage SGLT2 inhibitor